Authors: RIDOLFI R FLAMINI E RICCOBON A DEPAOLA F MALTONI R GARDINI A RIDOLFI L MEDRI L POLETTI G AMADORI D

Citation: R. Ridolfi et al., ADJUVANT ADAPTIVE IMMUNOTHERAPY WITH TUMOR-INFILTRATING LYMPHOCYTES AND MODULATED DOSES OF INTERLEUKIN-2 IN 22 PATIENTS WITH MELANOMA, COLORECTAL AND RENAL-CANCER, AFTER RADICAL METASTASECTOMY, AND IN 12 ADVANCED PATIENTS, Cancer immunology and immunotherapy, 46(4), 1998, pp. 185-193

Authors: FLAMINI E COTIGNOLI T FRASSINETI GL ROSTI G DEPAOLA F MANCINI D

Citation: E. Flamini et al., IMMUNOCYTOCHEMICAL (ICC) DETECTION OF MINIMAL RESIDUAL DISEASE IN BONE-MARROW AND PBPC IN BREAST-CANCER PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY, Bone marrow transplantation, 21, 1998, pp. 197-197

Authors: RIDOLFI R DEPAOLA F FLAMINI E RICCOBON A RIDOLFI L

Citation: R. Ridolfi et al., ADOPTIVE IMMUNOTHERAPY (TIL-2) AFTER METASTASECTOMY IN 34 PATIENTS WITH MELANOMA, COLORECTAL AND RENAL-CARCINOMA(IL), European journal of cancer, 33, 1997, pp. 64-64

Authors: ZOLI W FLAMIGNI A FRASSINETI GL BAJORKO P DEPAOLA F MILANDRI C AMADORI D GASPERICAMPANI A

Citation: W. Zoli et al., IN-VITRO ACTIVITY OF TAXOL AND TAXOTERE IN COMPARISON WITH DOXORUBICIN AND CISPLATIN ON PRIMARY-CELL CULTURES OF HUMAN BREAST CANCERS, Breast cancer research and treatment, 34(1), 1995, pp. 63-69

Authors: AMADORI D BERTONI L FLAMIGNI A SAVINI S DEGIOVANNI C CASANOVA S DEPAOLA F AMADORI A GIULOTTO E ZOLI W

Citation: D. Amadori et al., ESTABLISHMENT AND CHARACTERIZATION OF A NEW CELL-LINE FROM PRIMARY HUMAN BREAST-CARCINOMA, Breast cancer research and treatment, 28(3), 1993, pp. 251-260